AnaptysBio, Inc. (ANAB) Social Stream



AnaptysBio, Inc. (ANAB): $19.98

-0.55 (-2.68%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ANAB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Anaptysbio Inc (ANAB) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Anaptysbio Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 6 $50 $19 $35 $25.05 39.72%
2022-03-07 6 $50 $25 $36 $25.05 43.71%
2022-03-15 6 $50 $25 $36.166 $25.05 44.38%
2022-03-18 7 $50 $24 $36 $25.05 43.71%

The Trend in the Analyst Price Target


ANAB's average price target has moved up $17.57 over the prior 23 months.

ANAB reports an average of 30.07% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 5 50 19 31.80 22.80 39.47%
2021-06-26 6 50 19 33.67 26.44 27.34%
2021-08-05 6 50 19 33.67 23.95 40.58%
2021-11-08 6 50 19 35.00 37.46 -6.57%
2021-11-26 6 50 25 36.00 31.12 15.68%

ANAB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.71 2 0 4 1 1 7

The Trend in the Broker Recommendations


Over the past 39 weeks, ANAB's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Anaptysbio Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -480.14% of that group.
  • In the context of Pharmaceutical Products stocks, Anaptysbio Inc's upside potential (average analyst target price relative to current price) is higher than 138.58% of them.
  • Anaptysbio Inc's number of analysts covering the stock is greater than 241.37% of stocks in the mid market cap category.
  • ANAB has a greater average analyst price target than 405.75% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Anaptysbio Inc are AMTI, AMRX, and AMRN.

What is the outlook for ANAB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6218 seconds.